以下文章来源于量子位智库 ，作者AI 100访谈 量子位智库 . 连接AI创新，提供产业研究 分析师 刘萌媛 奕然 量子位智库 | 公众号 AI123All AI健康管理赛道竞争如火如荼，面向生活场景中的健康管理产品层出不穷，产品定位、界面设计、功能排布以及商业模式和盈利模式各有区 别。 整体来看，传统健康管理产品依据自身定位推出AI新功能，如AI教练、AI体重管理助手；AI原生产品注重AI功能应用以提升效率和体验，如AI 识图测热量、个性化交互助手等。 但是，消费级AI健康管理赛道是一个 大众化程度高且分散的市场 ，产品差异化程度相对不强，用户区分度不高，功能基本围绕 "记录+个性 化方案定制" 两个方面进行。 在这样的市场格局下，AI健康管理赛道面临的困惑与问题也愈发明显： 针对这些问题，量子位智库邀请了 小卡健康 及其产品负责人 李雅 ，进行了一场深入交流。 在这次访谈中，李雅表示小卡健康的核心定位是 每个人的专属AI营养师 ，可以用AI拍照测热量、语义识别用户饮食和运动行为并自动记录， AI营养师能给出个性化营养方案等。结合小卡健康的实例，我们也看到 AI原生产品在健康管理赛道竞争布局的差异化策略 ， ...

Core Viewpoint - The company held an online investor meeting on September 19, 2025, to discuss performance and new products, indicating a proactive approach to investor relations [1][2]. Performance and Strategy - In Q2 2025, the company's net profit attributable to shareholders was 19.35 million, a decrease from 22.94 million in Q1 2025, attributed to external macroeconomic factors such as U.S. tariffs [3]. - The company aims to achieve a net profit target of 80 million for the year through market expansion, product optimization, cost reduction, and detailed management strategies [3]. New Product Highlights - The upcoming smart ring will feature standard monitoring functions like blood oxygen, sleep, and heart rate, along with cardiovascular monitoring capabilities [4]. - The sales strategy includes leveraging the company's brand in the domestic market and focusing on large clients and remote patient monitoring (RPM) in international markets [4]. Cardiovascular AI Model Progress - The cardiovascular AI model is a key component of the company's health management services, utilizing wearable devices to collect physiological data for real-time analysis and intervention [5]. Stock Price and Operational Status - The company reassured that its operations are normal despite stock price fluctuations, which are influenced by multiple factors [6]. - In the first half of 2025, the company reported a net profit of 42.29 million, a year-on-year increase of 21.35%, and has implemented a semi-annual dividend [6]. Management Changes - Recent management adjustments are aimed at aligning with the latest strategic goals, with key personnel bringing valuable experience to enhance operational efficiency [7][8]. Market Value Aspirations - The management is focused on creating long-term value for shareholders and aims to enhance its position as a leading provider of medical monitoring devices, although specific plans for achieving a market value of 100 billion have not been disclosed [9].

Financial Performance - In Q2 2025, the company's net profit attributable to shareholders was CNY 19.35 million, a decrease from CNY 22.94 million in Q1 2025, primarily due to external macroeconomic factors [1] - For the first half of 2025, the net profit reached CNY 42.29 million, representing a year-on-year growth of 21.35% [2] - The company aims to achieve a full-year net profit target of CNY 80 million through various strategic measures [2] Product Development - The company’s smart ring has completed hardware development and passed consumer certification, with major clients already receiving samples [2] - The smart ring will offer advanced monitoring features beyond typical products, including cardiovascular status assessment [3] - The cardiovascular AI model has been developed to provide real-time health monitoring and intervention plans [3] Management and Strategy - Recent management changes are aimed at aligning with the latest strategic goals, enhancing operational efficiency [4] - The company has seen a significant turnaround in profitability, moving from a net loss of CNY 32.36 million in 2022 to a profit of CNY 34.37 million in 2023, and CNY 61.36 million in 2024 [5] - The management is focused on long-term value creation and aims to enhance the company's market position through strategic upgrades and innovation [5] Market Position and Investor Relations - The company reassured investors that its operations remain normal despite stock price fluctuations, which are influenced by multiple external factors [4] - The management is committed to transparency and timely information disclosure to maintain investor trust [5] - Plans to achieve a market capitalization of CNY 100 billion are part of the company's long-term vision [5]

Core Viewpoint - The collaboration between Meinian Health, Guofu Quantum, and Jingbeifang aims to explore the value release of digital assets in the healthcare sector, leveraging each company's strengths to innovate and upgrade the health industry [1][4]. Group 1: Collaboration and Strategic Goals - Meinian Health's subsidiary has signed a framework agreement with Guofu Quantum and Jingbeifang to explore comprehensive business opportunities in the digital asset RWA (Real World Asset) field [1]. - The partnership will focus on the tokenization of medical assets under the regulatory frameworks of mainland China and Hong Kong, aiming to reshape the value chain in the healthcare sector [1][4]. - This collaboration is expected to transform Meinian Health from a "health examination service provider" to a "medical data technology platform," enhancing its cash flow structure and expanding its business capabilities [4]. Group 2: Asset and Data Strengths - As of 2024, Meinian Health operates 576 health examination centers equipped with advanced medical devices, establishing a solid foundation of tangible assets [2]. - The company has served over 200 million people, with more than 25 million health examinations conducted in 2024, accumulating extensive multimodal health data [2][9]. - Meinian Health has developed AI applications for health management, including intelligent health managers and disease risk prediction models, which enhance its service offerings and operational efficiency [2][8]. Group 3: Research and Development Achievements - Meinian Health has led a national key research project to build a health examination big data cloud platform, gathering over 130 million health examination records, which supports the value of its data assets [6][7]. - The company has published numerous research papers based on its health examination data, contributing to significant findings in public health and disease prevention [17][18]. - Collaborations with prestigious medical institutions have resulted in breakthroughs in various health-related research projects, further validating the commercial potential of its data [16][18]. Group 4: Unique Data Advantages - Meinian Health's health examination data focuses on asymptomatic populations, providing unique insights for early disease detection and prevention [11]. - The data's medical-grade accuracy and comprehensive multimodal integration enhance its value for serious medical research compared to consumer-grade health monitoring devices [12][13]. - The company's annual health examinations create a natural cohort tracking mechanism, ensuring high compliance and data integrity for longitudinal studies [14][15].

Group 1: Medical Insurance Development - The National Medical Insurance Bureau emphasizes the need to empower the pharmaceutical industry and implement measures to support high-quality development of innovative drugs [1][2] - By mid-2025, significant progress is expected in medical insurance, including an increase in the number of insured individuals under maternity insurance to 253 million, with expenditures reaching 67.832 billion yuan in the first half of the year [1] - The meeting highlighted the importance of direct settlement of medical expenses for drug procurement enterprises, with an average settlement cycle reduced to within 30 days [1][2] Group 2: Maternity Insurance and Long-term Care - The meeting encourages regions to include flexible employment workers, migrant workers, and new employment forms in maternity insurance coverage, while also exploring basic service packages for prenatal check-ups [3] - Long-term care insurance will be comprehensively implemented, with a focus on planning and supporting community-based care services [3] Group 3: Healthcare System Reform - The meeting calls for the reform of medical service pricing and the expansion of immediate settlement of medical insurance funds to healthcare institutions [2] - There is a push for the integration of technology in medical insurance, transitioning from passive payment to proactive empowerment and health investment [3]

Group 1: Medical Insurance Development - The National Medical Insurance Administration emphasizes empowering the pharmaceutical industry and implementing measures to support high-quality development of innovative drugs [1][2] - By mid-2025, significant progress is expected in medical insurance, including an increase in the number of insured individuals under maternity insurance to 253 million and total maternity insurance benefits expenditure reaching 67.832 billion [1] - The meeting highlights the need for a comprehensive adjustment of the national medical insurance drug catalog and the establishment of a commercial health insurance innovative drug catalog [2] Group 2: Maternity Insurance and Long-term Care - The meeting encourages regions to include flexible employment workers, migrant workers, and new employment forms in maternity insurance coverage, while also exploring basic service packages for prenatal check-ups [3] - There is a push for the implementation of long-term care insurance, with a focus on planning and supporting long-term care services at the community level [3] - The meeting calls for the integration of long-term care services with commercial insurance products to enhance accessibility and suitability of care [3] Group 3: Digital Transformation in Medical Insurance - The meeting aims to transition the medical insurance system from passive payment to proactive empowerment, focusing on health investment rather than just disease compensation [3] - There is an emphasis on promoting research in disease prediction modeling, pharmacoeconomics, and disease attribution analysis in collaboration with medical institutions and research organizations [3] - The integration of technology in medical insurance is encouraged to foster new medical services, AI health management, and smart elderly care [3]

Core Viewpoint - The article discusses the rapid growth and potential of AI in healthcare, highlighting its transformative impact on patient management and the healthcare system in China, while also addressing the challenges and limitations faced by AI technologies in this sector [2][4][10]. Group 1: AI in Healthcare Services - AI services are increasingly being adopted by patients for health management, with applications such as report interpretation and intelligent triage leading the trend [2][3]. - Major internet companies like JD Health, Alibaba Health, and Baidu Health are actively developing independent AI health management applications, indicating a competitive landscape [3][4]. - The AI health management market in China is projected to reach 25.9 trillion yuan by 2027, with a compound annual growth rate exceeding 20% [4]. Group 2: Impact on Traditional Healthcare - AI technologies are significantly changing the traditional healthcare system, allowing hospitals to serve a larger number of patients efficiently [5][10]. - AI can alleviate the burden on healthcare professionals by handling repetitive tasks, thus improving overall service efficiency [7][10]. - The integration of AI into healthcare aims to create a closed-loop system that connects various healthcare services, enhancing data collection and patient management [7][10]. Group 3: Challenges and Limitations - Despite the potential benefits, there are significant challenges in gaining public trust in AI healthcare solutions, with only 3.59% of people believing AI can fully replace doctors [13][14]. - The complexity of integrating AI into healthcare requires deep collaboration with medical professionals to ensure the accuracy and reliability of AI systems [14][15]. - Legal and regulatory challenges, particularly concerning data privacy and the definition of responsibility in AI applications, pose significant hurdles for the industry [15][16].

Core Viewpoint - The article discusses the rapid growth and adoption of AI-driven health management services in China, highlighting the competitive landscape among major internet companies and the potential impact on the healthcare system [5][14][16]. Group 1: Market Trends and Growth Potential - The AI health management market in China is projected to reach 2.59 trillion yuan by 2027, with a compound annual growth rate exceeding 20% [4]. - Over 90% of working individuals are affected by sub-health conditions, creating a significant demand for AI health management solutions [3][4]. - Major internet companies like JD Health, Alibaba Health, and Baidu Health are actively developing independent AI health management applications, indicating a fierce competition in the sector [3][4][10]. Group 2: AI Integration in Healthcare - AI technologies are being utilized to enhance patient care, with hospitals reporting significant increases in patient consultations through AI systems [6][7]. - AI health management products are emerging to cover pre-consultation and post-discharge follow-ups, addressing gaps in traditional healthcare services [8][9]. - The integration of AI with offline healthcare services aims to create a seamless healthcare experience for users, improving data collection and service efficiency [10][11]. Group 3: Challenges and Considerations - Despite the promising market, there are challenges in gaining trust from the public, as only 3.59% of people believe AI can fully replace doctors [18][19]. - The complexity of healthcare services requires AI systems to connect with a wide range of medical resources, which is crucial for effective health management [16][23]. - Legal and regulatory issues surrounding data privacy and AI accountability remain significant hurdles for the industry [28][29][30].

Core Insights - The event "With Love, Together: Million Lottery" hosted by Rietter on July 1, 2025, showcased the company's commitment to user engagement and innovation in health management through the launch of the AI Health Toilet IX9 [1][2] - Rietter's "Lifetime Rights Plan" was initiated in April 2025, aiming to enhance customer loyalty and brand interaction by offering significant rewards to users of their smart toilets [2][4] - The AI Health Toilet IX9 represents a significant advancement in home health management, featuring an AI system for seamless health monitoring and various patented technologies ensuring high sanitation standards [3][5] User Engagement and Brand Strategy - The lottery event was supervised by the Xiamen Public Notary Office to ensure fairness, and it involved 101 winners receiving the AI Health Toilet IX9, emphasizing transparency in the brand's promotional activities [2][4] - The event also leveraged social media platforms to enhance user interaction, encouraging participants to share their experiences and thereby strengthening brand advocacy [4][6] - Rietter's strategy integrates technology, health, and emotional connection, aiming to create a sustainable and socially responsible brand image through initiatives like the Lifetime Rights Plan and educational donations [4][6] Product Features and Innovations - The AI Health Toilet IX9 includes advanced features such as real-time monitoring of 14 physiological indicators and the ability to generate visual health reports, enhancing its role as a personal health management center [5][6] - The product employs innovative sanitation technologies, achieving a 99.9% sterilization rate and receiving multiple certifications, which positions it as a leader in the smart bathroom segment [3][5] - User testimonials during the event highlighted the practical benefits of the product, reinforcing the brand's commitment to improving family health and well-being through technology [3][4]

Group 1 - The core focus of Nanjing Software is on the health management sector, specifically through its initiative "Chashou Health," which aims to leverage institutional innovation and core capabilities in government information technology to gain a competitive edge in the health industry [1] - Chashou Health is positioned as a closed-loop health management service, offering free AI platform health knowledge services and aiming to build an industrial ecosystem with future revenue from personalized value-added services [1] - The company plans to collaborate closely with regional health commissions and local government systems to integrate health management services, targeting a high-quality startup phase [1] Group 2 - The three-year goal for Chashou Health is to validate the effectiveness of AI in health management and to establish itself as the first choice for users in health management services [1] - The health model integrates knowledge from experts at Peking University Medical School and top-tier hospitals, with plans to expand collaborations with experts across various fields [1] - Currently, the service is not subject to medical device regulations, but the company intends to keep pace with policy changes and actively apply for Class III certifications in the future [1] Group 3 - Nanjing Software has a strong partnership with Huawei, which will continue to develop in the health sector [1] - Chashou Health operates as an independent entity, receiving resource support while using AI to restructure traditional business models [1]